Coenzyme Q10 biosynthesis pathway (None standardized)

The Coenzyme Q10 biosynthesis pathway refers to a multi-step metabolic route essential for producing Coenzyme Q10 (ubiquinone), a lipid-soluble molecule found in most cell membranes, especially within mitochondria. CoQ10 plays indispensable roles in energy conversion within the mitochondrial electron transport chain, both as a central electron carrier supporting ATP generation and as a potent antioxidant counteracting oxidative damage. In humans, synthesis involves the mevalonate pathway (shared with cholesterol biosynthesis) to form its isoprenoid side chain and separate hydroxylation and condensation reactions for the benzoquinone ring, mediated by multiple nuclear-encoded enzymes and protein complexes. Dysfunction in the pathway is linked to mitochondrial, cardiovascular, neurodegenerative, and muscular diseases. The pathway is regulated nutritionally and pharmacologically (notably by statins), and oral supplementation is used as adjunctive therapy for several conditions, though efficacy and absorption limitations remain.

Other names

CoQ10 biosynthesisUbiquinone biosynthetic pathwayMevalonate pathway

Statins inhibit HMG-CoA reductase, decreasing mevalonate pathway intermediates required for CoQ10 biosynthesis. Coenzyme Q10 supplementation increases cellular/tissue CoQ10, enhances mitochondrial function, reduces oxidative stress, improves blood flow. Some drugs (e.g., idebenone, a synthetic analog) may act as electron carriers or antioxidants.